tiprankstipranks
Trending News
More News >
Hansoh Pharmaceutical Group Company Limited (HK:3692)
:3692
Hong Kong Market
Advertisement

Hansoh Pharmaceutical Group Company Limited (3692) Financial Statements

Compare
4 Followers

Hansoh Pharmaceutical Group Company Limited Financial Overview

Hansoh Pharmaceutical Group Company Limited's market cap is currently HK$196.55B. The company's EPS TTM is HK$0.30601460680000003; its P/E ratio is 43.16; and it has a dividend yield of 0.95%. Hansoh Pharmaceutical Group Company Limited is scheduled to report earnings on March 21, 2025, and the estimated EPS forecast is HK$0.39. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 12.26B¥ 10.10B¥ 9.38B¥ 9.94B¥ 8.69B
Gross Profit¥ 11.16B¥ 9.07B¥ 8.51B¥ 9.06B¥ 7.89B
Operating Income¥ 4.03B¥ 2.84B¥ 2.61B¥ 2.82B¥ 2.77B
EBITDA¥ 4.25B¥ 4.20B¥ 2.93B¥ 3.08B¥ 2.99B
Net Income¥ 4.37B¥ 3.28B¥ 2.58B¥ 2.71B¥ 2.57B
Balance Sheet
Cash & Short-Term Investments¥ 23.39B¥ 24.86B¥ 21.63B¥ 18.94B¥ 13.73B
Total Assets¥ 31.66B¥ 33.04B¥ 30.00B¥ 27.16B¥ 20.79B
Total Debt¥ 117.89M¥ 4.30B¥ 4.38B¥ 3.83B¥ 92.75M
Net Debt¥ -22.50B¥ -18.13B¥ -13.24B¥ -10.87B¥ -4.19B
Total Liabilities¥ 2.98B¥ 7.24B¥ 7.35B¥ 7.13B¥ 2.92B
Stockholders' Equity¥ 28.68B¥ 25.79B¥ 22.65B¥ 20.03B¥ 17.88B
Cash Flow
Free Cash Flow¥ 3.64B¥ 2.90B¥ 2.47B¥ 2.12B¥ 962.83M
Operating Cash Flow¥ 3.86B¥ 3.12B¥ 2.74B¥ 2.58B¥ 2.39B
Investing Cash Flow¥ -1.39B¥ 1.07B¥ -5.94B¥ -2.26B¥ -2.87B
Financing Cash Flow¥ -6.07B¥ -753.70M¥ -818.14M¥ 3.42B¥ -1.04B
Currency in CNY

Hansoh Pharmaceutical Group Company Limited Earnings and Revenue History

Hansoh Pharmaceutical Group Company Limited Debt to Assets

Hansoh Pharmaceutical Group Company Limited Cash Flow

Hansoh Pharmaceutical Group Company Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis